UCL Computational Cancer Collaboratorium Symposium
08 November 2023, 9:30 am–2:00 pm
![UCL Computational Cancer Collaboratorium logo UCL Computational Cancer Collaboratorium logo](https://www.ucl.ac.uk/research/domains/sites/research_domains/files/styles/large_image/public/events/ccc_logo.png?itok=LA9baENZ)
Introducing the first ever symposium from the UCL Computational Cancer Collaboratorium, connecting the computational cancer research community across UCL.
This event is free.
Event Information
Open to
- All
Availability
- Yes
Cost
- Free
Organiser
-
Dr Ben Hall
Location
-
Lecture Theatre 2Cruciform BuildingGower StreetLondonWC1E 6BTUnited Kingdom
The UCL Computational Cancer Collaboratorium is a new initiative drawing together the extensive and diverse expertise in computational cancer research at UCL to enhance collaborative working and infrastructure supporting this research. The Collaboratorium’s first symposium will address “machine learning for small data in cancer research”; using novel computational methods to make discoveries from small, but rich laboratory datasets and clinical datasets for rare cancers. It will bring together researchers developing new computational methods with experimental and clinical cancer researchers seeking computational approaches to extract new insights from their data, to discuss challenges, solutions and how best to build our community.
About the Speakers
Dr Jamie Dean
Senior Research Fellow and Junior Group Leader in Computational Radiation Oncology at UCL Faculty of Engineering Science
An Introduction to Machine Learning for Small Data and its Application to Cancer
More about Dr Jamie DeanProfessor Sibylle Mittnacht
Professor of Cell and Molecular Oncology, at UCL Faculty of Medical Sciences
Tracking cell fate reporters over time to delineate concepts of cancer drug tolerance
More about Professor Sibylle MittnachtDr Matt Lechner
Associate Professor of Surgery and Honorary Consultant Rhinologist and ENT Surgeon, at UCL Faculty of Medical Sciences
International collaborations and global outreach with a focus on betel nut-induced oral cancer
More about Dr Matt Lechner